Stabilize an acute episode
Unstable or pulseless VT requires immediate emergency care. Treatment may include electrical cardioversion or defibrillation and management of reversible causes.
Medically reviewed by Dr. Kathy Shi, M.D., Ph.D. · SinoUnited Health
Ventricular tachycardia care in Shanghai
Understanding ventricular tachycardia clearly
Ventricular tachycardia is not one uniform condition. Assessment begins by confirming the rhythm, determining whether structural heart disease is present, understanding symptoms and urgency, and identifying the safest treatment strategy for the individual patient.
← Return to Dr. Ouyang’s profile
Understanding the condition
What is ventricular tachycardia?
Ventricular tachycardia, often shortened to VT, is a rapid heart rhythm that begins in the ventricles, the lower pumping chambers of the heart. It may occur as a brief, self-terminating episode or continue as a sustained rhythm that requires urgent treatment.
The clinical meaning of VT depends on its duration, symptoms, effect on blood pressure, underlying heart condition and the rhythm’s specific mechanism. VT may be associated with heart muscle disease or scar, previous heart attack, inflammation, inherited electrical conditions, medication or electrolyte effects, or it may occur without evident structural heart disease.
Because some forms can reduce the heart’s ability to pump blood and may progress to cardiac arrest, a documented or suspected episode requires appropriate medical evaluation. The rhythm should be confirmed from an ECG, monitor, implanted device recording or another clinician-reviewed tracing.
Symptoms and urgency
VT can range from subtle symptoms to a medical emergency
Symptoms vary with the speed and duration of the rhythm, heart function and other medical conditions. A short episode may cause few symptoms, while sustained VT may cause a rapid deterioration.
Palpitations
A rapid, pounding or forceful heartbeat.
Light-headedness
Dizziness, weakness or feeling close to fainting.
Breathing or chest symptoms
Shortness of breath, chest discomfort or reduced exercise tolerance.
Loss of consciousness
Fainting or sudden unresponsiveness may indicate an unstable rhythm.
Specialist assessment
Defining the rhythm and its clinical setting
A specialist review considers the rhythm tracing, whether episodes are sustained, symptoms, heart structure and function, possible underlying disease, previous treatment and the patient’s individual risk.
- 01Confirm and characterize the rhythm.
Review 12-lead ECGs, ambulatory monitoring, emergency records or recordings from an implanted device. - 02Assess heart structure and function.
Echocardiography and, in selected cases, cardiac magnetic resonance or other imaging may help identify scar or cardiomyopathy. - 03Look for causes and contributing factors.
The evaluation may consider coronary disease, inflammation, inherited conditions, medicines, electrolyte disturbance and relevant family history. - 04Assess future risk and treatment goals.
The significance of VT and the role of medication, an implanted defibrillator or ablation depend on the complete clinical picture.
Individualized treatment
Treatment depends on urgency, cause and future risk
No single treatment pathway applies to every form of VT. Acute treatment and long-term prevention are separate decisions, and several approaches may be used together.
Treat the underlying condition
Care may address coronary disease, heart failure, inflammation, electrolyte disturbance, medication effects or another contributing condition.
Reduce recurrence and risk
Depending on the case, clinicians may discuss antiarrhythmic medication, an implantable cardioverter-defibrillator, catheter ablation or a combination.
Plan follow-up
Rhythm monitoring, device checks, imaging and reassessment help guide longer-term care and response to treatment.
Rhythm-control treatment
When might VT catheter ablation be discussed?
This information is general. Only a clinician who has reviewed the individual case can advise whether a procedure is appropriate.
The type and origin of VT
Planning differs between idiopathic VT and VT related to scar or structural heart disease. ECG characteristics and cardiac imaging help define the likely mechanism and target.
Symptoms and recurrence
Ablation may be considered when episodes are recurrent or symptomatic, when VT causes implanted-defibrillator therapies, or when reducing rhythm burden is an important treatment goal.
Previous treatment
The discussion considers medication response, contraindications or side effects, prior ablation and the person’s overall heart condition.
Benefits, limits and risks
A specialist should explain the proposed mapping and ablation strategy, realistic goals, procedural risks, possibility of recurrence and whether additional treatment or an implanted defibrillator remains necessary.
Specialist experience
Complex ventricular-arrhythmia care with Dr. Feifan Ouyang
Dr. Ouyang’s clinical and academic work has included the mechanisms and catheter ablation of complex ventricular arrhythmias. Documented areas of experience include verapamil-sensitive left ventricular tachycardia, ventricular tachycardia arising near the aortic sinuses and selected epicardial ventricular tachycardias.
View Dr. Ouyang’s experience220+Manuscripts and papers across cardiac electrophysiology and arrhythmia care
China · GermanyTraining, clinical practice and electrophysiology laboratory leadership
Complex VTClinical and academic experience in ventricular-arrhythmia mechanisms and ablation
ShanghaiInvited arrhythmia specialist at Shanghai SinoUnited Hospital
Preparing for a consultation
Information that can make the first review more useful
The care team will explain how to share records securely. Do not send medical attachments through the initial website form.
Rhythm records
12-lead ECGs during VT, ambulatory-monitor reports, emergency records and implanted-device recordings.
Treatment history
Current and previous medicines, cardioversions, defibrillator therapies, ablations and relevant side effects.
Heart assessment
Echocardiogram, cardiac MRI, coronary-imaging or procedure reports, relevant diagnoses and family history.
Frequently asked questions
Questions patients often ask about ventricular tachycardia
These answers provide general education and do not replace an individual medical assessment.
Is ventricular tachycardia the same as supraventricular tachycardia?
No. VT begins in the ventricles, while supraventricular tachycardia begins above the ventricles. The distinction affects urgency, evaluation and treatment.
Is every episode of VT immediately life-threatening?
The severity varies, but sustained VT can be dangerous and requires prompt medical assessment. Risk depends on symptoms, blood pressure, heart function, underlying disease and the rhythm itself.
Does everyone with VT need an implanted defibrillator?
No single answer applies to everyone. An implantable cardioverter-defibrillator may be recommended in certain higher-risk situations, but the decision depends on the cause of VT, heart function and the person’s overall risk.
Can catheter ablation treat ventricular tachycardia?
Ablation can reduce recurrent VT in selected patients. The expected benefit, procedural strategy and whether other treatment remains necessary depend on the VT mechanism and clinical context.
Can VT return after ablation?
Yes. Recurrence is possible, particularly when the underlying heart condition or arrhythmia substrate changes over time. Follow-up and sometimes additional treatment may be required.
What records are most useful for a specialist review?
A 12-lead ECG recorded during VT is especially valuable. Device recordings, monitoring reports, imaging, prior procedure reports and a complete medication history can also help.
Request specialist care
Would you like a ventricular tachycardia review?
Share basic contact information and the SinoUnited international care team can help coordinate the next appropriate step with Dr. Ouyang’s service.
Request a consultation For emergencies, contact local emergency services immediately.
Clinical references
Guidelines informing this page
- Zeppenfeld K, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal. 2022.
- Cronin EM, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020.
- American Heart Association. Tachycardia: Fast Heart Rate. Patient information reviewed for this page.
Medically reviewed by: Dr. Kathy Shi, M.D., Ph.D.Affiliation: SinoUnited HealthReview date: July 20, 2026